Rhinovirus infections in myelosuppressed adult blood and marrow transplant recipients

Clinical Infectious Diseases

Volumn 29, Issue 3, 1999, Pages 528-532

  Ghosh, S ^a   Champlin, R ^a   Couch, R ^a   Englund, J ^a   Raad, I ^a   Malik, S ^a   Luna, M ^a   Whimbey, E ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHOTREXATE; METHYLPREDNISOLONE; TACROLIMUS; THIOTEPA; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; ASPERGILLOSIS; BLOOD TRANSFUSION; BONE MARROW SUPPRESSION; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; IMMUNE DEFICIENCY; INTERSTITIAL PNEUMONIA; LUNG LAVAGE; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; RESPIRATORY FAILURE; RHINOVIRUS; TRACHEOBRONCHIAL TOILET; UPPER RESPIRATORY TRACT INFECTION; VIRUS INFECTION; VIRUS PNEUMONIA;

EID: 0032843160     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/598627     Document Type: Article

References (26)

1. Gwaltney JM Jr. Rhinovirus. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett's principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone, 1995:1656-63.
2. Couch RB, Rhinoviruses. In: Fields BN, Knipe DM, eds. Fields virology. 3rd ed. Vol 23. New York: Raven Press, 1996:713-33.
3. Pitkaranta A, Hayden FG. What's new with common colds? Pathogenesis and diagnosis. Infections in Medicine 1998;15:50 3, 57-9.
4. Nicholson KG, Kent J, Hammersley V, Cancio E. Risk factors for lower respiratory complications of rhinovirus infections in elderly people living in the community: prospective cohort study. BMJ 1996;313: 1119-23.
5. George RB, Mogabgab WJ. Atypical pneumonia in young men with rhinovirus infections. Ann Intern Med 1969;1073-8.
6. Chidekel AS, Rosen CL, Bazzy AR. Rhinovirus infection associated with Serious lower respiratory illness in patients with bronchopulmonary dysplasia. Pediatr Infect Dis J 1997;16:43-7.
7. Gern JE, Calhoun W, Swenson C, Shen G, Busse WW. Rhinovirus infection preferentially increases lower airway responsiveness in allergic subjects. Am J Respir Crit Care Med 1997;155:1872-6.
8. Wald TG, Shult P, Krause P, Miller BA, Drinka P, Gravenstein S. A rhinovirus outbreak among residents of a long-term care facility. Ann Intern Med 1995;123:588-93.
9. Winther B. Effects on the nasal mucosa of upper respiratory viruses (common cold). Dan Med Bull 1994;41:193-204.
10. Naclerio RM, Proud D, Togias AG, et al. Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med 1985;313:65-70.
11. Bardin PG, Fraenkel DJ, Sanderson G, Lampe F, Holgate ST. Lower airways inflammatory response during rhinovirus colds. Int Arch Allergy Immunol 1995;107:127-9.
12. Naclerio RM, Proud D, Lichtenstein LM, et al. Kinins are generated during experimental rhinovirus colds. J Infect Dis 1988;157:133-42.
13. Proud D, Naclerio RM, Gwaltney JM, Hendley JO. Kinins are generated in nasal secretions during natural rhinovirus colds. J Infect Dis 1990; 161:120-3.
14. Proud D, Gwaltney JM Jr, Hendley JO, Dinarello CA, Gillis S, Schleimer RP. Increased levels of interleukin-I are detected in nasal secretions of volunteers during experimental rhinovirus colds. J Infect Dis 1994;169: 1007-13.
15. Douglass JA, Dhami D, Gurr CE, et al. Influence of interleukin-8 challenge in the nasal mucosa in atopic and nonatopic subjects. Am J Respir Crit Care Med 1994;150:1108-13.
16. Calhoun WJ, Dick EC, Schwartz LB, Busse WW. A common cold virus, rhinovirus 16, potentiates airway inflammation after segmental antigen bronchoprovocation in allergic subjects. J Din Invest 1994;94:2200-8.
17. Whimbey E, Champlin RE, Couch RB, et al. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin Infect Dis 1996;22:778-82.
18. Whimbey E, Englund JA, Couch RB. Community respiratory virus infections in immunocompromised patients with cancer. Am J Med 1997;102:10-8.
19. Cate TR, Couch RB, Fleet WF, Griffith WR, Gerone PJ, Knight V. Production of tracheobronchitis in volunteers with rhinovirus in a small-particle aerosol. Am J Epidemiol 1965;81:95-105.
20. Gern JE, Galagan DM, Jarjour NN, Dick EC, Russe WW. Detection of rhinovirus RNA in lower airway cells during experimentally induced infection. Am J Respir Crit Care Med 1997;155:1159-61.
21. Monto AS, Bryan ER, Ohmit S. Rhinovirus infections in Tecumseh, Michigan: frequency of illness and number of serotypes. J Infect Dis 1987;156:43-9.
22. Greenberg SB, Atmar RL, Glczen WP. Spectrum of clinical illnesses due to "common cold" viruses in hospitalised patients [abstract no 8]. Clin Infect Dis 1997;25:356.
23. Pitkaranta A, Hayden FG. What's new with common colds? Complications and management. Infections in Medicine 1998;15:117 8, 121-2, 124-8.
24. Schiff GM, McKinlay MA, Sherwood JR. Oral efficacy of VP 63843 in coxsackievirus A21 infected volunteers [abstract no H-43]. In: Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy (New Orleans). Washington, DC: American Society for Microbiology, 1996:171.
25. Rotbart HA, Jones A, Novelli V, Blanche S, Webster ADB. Pleconaril treatment of chronic enteroviral central nervous system infections in children with agammaglobulinemia [abstract no H-126]. In: Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (Toronto). Washington, DC: American Society for Microbiology, 1997:236.
26. Raad I, Abbas J, Whimbey E. Infection control of nosocomial respiratory viral disease in the immunocompromised host. Am J Med 1997;102: 48-52.